Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021

Gold, Jeremy A.W.; Adjei, Stacey; Gundlapalli, Adi V.; Huang, Ya-Lin A.; Chiller, Tom; Benedict, Kaitlin; Toda, Mitsuru

doi:10.3201/eid2907.221771

Advanced Search

Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

Advanced Search
Custom Query

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Clear All

Query Builder

Query box

Clear All

For additional assistance using the Custom Query please check out our Help Page

i

Increased Hospitalizations Involving Fungal Infections during COVID-19 Pandemic, United States, January 2020–December 2021

7 2023
By Gold, Jeremy A.W. ; Adjei, Stacey ; Gundlapalli, Adi V. ; ...
http://dx.doi.org/10.3201/eid2907.221771
Source: Emerg Infect Dis. 2023; 29(7):1433-1437

[PDF-727.00 KB]

English

Details Supporting Files You May Also Like

Details:

Alternative Title:

Emerg Infect Dis
Personal Author:

Gold, Jeremy A.W. ; Adjei, Stacey ; Gundlapalli, Adi V. ; Huang, Ya-Lin A. ; Chiller, Tom ; ... More +

Gold, Jeremy A.W. ; Adjei, Stacey ; Gundlapalli, Adi V. ; Huang, Ya-Lin A. ; Chiller, Tom ; Benedict, Kaitlin ; Toda, Mitsuru Less -
Description:

Hospitalizations involving fungal infections increased 8.5% each year in the United States during 2019-2021. During 2020-2021, patients hospitalized with COVID-19-associated fungal infections had higher (48.5%) in-hospital mortality rates than those with non-COVID-19-associated fungal infections (12.3%). Improved fungal disease surveillance is needed, particularly during respiratory virus pandemics.
Subjects:

[+]

Actinomycosis Aspergillosis Blastomycosis Coccidioidomycosis COVID-19 Cryptococcosis Histoplasmosis Humans Mucormycosis Mycoses Nocardia Infections Pandemics
Source:

Emerg Infect Dis. 2023; 29(7):1433-1437
Pubmed ID:

37347805
Pubmed Central ID:

PMC10310397
Document Type:

Journal Article
Genre:

Dispatch
Place as Subject:

United States
Volume:

29
Issue:

7
Collection(s):

Emerging Infectious Diseases
Main Document Checksum:

[+]

urn:sha256:08e9db32d3c19ea4ccda0ebd02658be2f6385408923b0abafc0c00e402216f33
Download URL:

https://stacks.cdc.gov/view/cdc/130806/cdc_130806_DS1.pdf
File Type:

	22-1771-F.gif	gif
	22-1771-F.jpg	jpeg
	22-1771-Techapp-s1.pdf	pdf
	22-1771.nxml	xml

More +